ArticleInternational journal of oncology2016

Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate.

Shiori Sugai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.